A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT

被引：0
作者：
Jingtao Gao
Mengqiu Gao
Jian Du
Yu Pang
Gary Mao
Nacer Lounis
Nyasha Bakare
Yanxin Jiang
Ying Zhan
Yuhong Liu
Liang Li
机构：
[1] Beijing Chest Hospital,Clinical Center On TB
[2] Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute,Department of Tuberculosis
[3] Beijing Chest Hospital,Department of Bacteriology and Immunology
[4] Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,undefined
[5] Beijing Chest Hospital,undefined
[6] Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute,undefined
[7] Janssen Global Public Health,undefined
[8] Janssen Research & Development,undefined
[9] Janssen Pharmaceutica,undefined
[10] Janssen China Research & Development,undefined
[11] Innovation Alliance On Tuberculosis Diagnosis and Treatment (Beijing) [IATB],undefined
来源：
Trials | / 25卷
关键词：
Tuberculosis; Bedaquiline; China; Oral Short-course regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
[1]   A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT [J].
Gao, Jingtao ;
Gao, Mengqiu ;
Du, Jian ;
Pang, Yu ;
Mao, Gary ;
Lounis, Nacer ;
Bakare, Nyasha ;
Jiang, Yanxin ;
Zhan, Ying ;
Liu, Yuhong ;
Li, Liang .
TRIALS, 2024, 25 (01)
[2]   New All-Oral Short-term Regimen for Multidrug-Resistant Tuberculosis: A Semi-randomized Controlled Trial Conducted in China [J].
Jing, Wei ;
Wang, Qingfeng ;
Wang, Jun ;
Ma, Liping ;
Huang, Mailing ;
Wang, Jing ;
Du, Yadong ;
Cai, Baoyun ;
Shi, Wenhui ;
Li, Qi ;
Li, Xuelian ;
Chu, Naihui ;
Nie, Wenjuan .
OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02)
[3]   TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II–III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis [J].
Catherine Berry ;
Philipp du Cros ;
Katherine Fielding ;
Suzanne Gajewski ;
Emil Kazounis ;
Timothy D. McHugh ;
Corinne Merle ;
Ilaria Motta ;
David A. J. Moore ;
Bern-Thomas Nyang’wa .
Trials, 23
[4]   Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China [J].
Du, Yadong ;
Qiu, Chao ;
Chen, Xiaohong ;
Wang, Jing ;
Jing, Wei ;
Pan, Hongqiu ;
Chen, Wei ;
Liu, Yufeng ;
Li, Chunxiang ;
Xi, Xiu'e ;
Yin, Hongyun ;
Zeng, Jianfeng ;
Zhang, Xia ;
Xu, Tao ;
Wang, Qingfeng ;
Guo, Ru ;
Wang, Jun ;
Pang, Yu ;
Chu, Naihui .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) :1047-1054
[5]   TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis [J].
Berry, Catherine ;
du Cros, Philipp ;
Fielding, Katherine ;
Gajewski, Suzanne ;
Kazounis, Emil ;
McHugh, Timothy D. ;
Merle, Corinne ;
Motta, Ilaria ;
Moore, David A. J. ;
Nyang'wa, Bern-Thomas .
TRIALS, 2022, 23 (01)
[6]   Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China [J].
Tang, Shenjie ;
Yao, Lan ;
Hao, Xiaohui .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[7]   A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis [J].
Martinez-Camprecios, Joan ;
Aznar, Maria Luisa ;
Zacarias, Adriano ;
Teran, Rafael ;
Nindia, Arlete ;
Espinosa-Pereiro, Juan ;
Aixut, Sandra ;
Ramos, Maria Eugenia ;
Nicolau, Marcos Jose ;
Sulleiro, Elena ;
Tortola, Maria Teresa ;
Sanchez-Montalva, Adrian ;
Molina, Israel .
JOURNAL OF INFECTION, 2024, 89 (06)
[8]   Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis [J].
Pai, Helen ;
Ndjeka, Norbert ;
Mbuagbaw, Lawrence ;
Kaniga, Kone ;
Birmingham, Eileen ;
Mao, Gary ;
Alquier, Lori ;
Davis, Kourtney ;
Bodard, Arianne ;
Williams, Abeda ;
Van Tongel, Magalie ;
Thoret-Bauchet, Florence ;
Omar, Shaheed, V ;
Bakare, Nyasha .
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[9]   An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis A Multicenter, Randomized Controlled Clinical Trial (the NExT Study) [J].
Esmail, Aliasgar ;
Oelofse, Suzette ;
Lombard, Carl ;
Perumal, Rubeshan ;
Mbuthini, Linda ;
Mahomed, Akhter Goolam ;
Variava, Ebrahim ;
Black, John ;
Oluboyo, Patrick ;
Gwentshu, Nelile ;
Ngam, Eric ;
Ackerman, Tertius ;
Marais, Linde ;
Mottay, Lynelle ;
Meier, Stuart ;
Pooran, Anil ;
Tomasicchio, Michele ;
Te Riele, Julian ;
Derendinger, Brigitta ;
Ndjeka, Norbert ;
Maartens, Gary ;
Warren, Robin ;
Martinson, Neil ;
Dheda, Keertan .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (10) :1214-1227
[10]   Efficacy and safety of the all-oral bedaquiline-containing regimen as treatment for pediatric multidrug/rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study [J].
Sun, Wen-Wen ;
Yang, Ming ;
Chen, Xiao-Hong ;
Fan, Li-Chao ;
Wu, Hao-Yu ;
Zhang, Shao-Jun ;
Chen, Yu ;
Fan, Lin .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (04) :219-227
1234